Dupilumab Improves Lung Function and Reduces Severe Exacerbations in Patients from China with Type 2 Asthma: A Subgroup Analysis of a Phase 3 Randomized Trial
- DOI
- 10.2147/jaa.s597499
- Published
- 2026-09
- Container
- Journal of Asthma and Allergy
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2147/jaa.s597499,
title = {Dupilumab Improves Lung Function and Reduces Severe Exacerbations in Patients from China with Type 2 Asthma: A Subgroup Analysis of a Phase 3 Randomized Trial},
author = {Qingling Zhang and Xiuhua Fu and Haohui Fang and Jie Lin and Arman Altincatal and Yvonne Huang and Jason H Kwah and Olivier Ledanois and Nanshan Zhong},
year = {2026},
journal = {Journal of Asthma and Allergy},
doi = {10.2147/jaa.s597499},
url = {https://doi.org/10.2147/jaa.s597499}
}RIS
TY - JOUR TI - Dupilumab Improves Lung Function and Reduces Severe Exacerbations in Patients from China with Type 2 Asthma: A Subgroup Analysis of a Phase 3 Randomized Trial AU - Qingling Zhang AU - Xiuhua Fu AU - Haohui Fang AU - Jie Lin AU - Arman Altincatal AU - Yvonne Huang AU - Jason H Kwah AU - Olivier Ledanois AU - Nanshan Zhong PY - 2026 JO - Journal of Asthma and Allergy DO - 10.2147/jaa.s597499 UR - https://doi.org/10.2147/jaa.s597499 ER -
APA
Zhang, Q., Fu, X., Fang, H., Lin, J., Altincatal, A., Huang, Y., Kwah, J. H., Ledanois, O., & Zhong, N. (2026). Dupilumab Improves Lung Function and Reduces Severe Exacerbations in Patients from China with Type 2 Asthma: A Subgroup Analysis of a Phase 3 Randomized Trial. Journal of Asthma and Allergy. https://doi.org/10.2147/jaa.s597499
Source records
- crossref · retrieved 2026-09-25T11:01:10.263Z